logo-loader
NASDAQ:ADAP

Adaptimmune Therapeutics PLC

Receive alerts
Market:
NASDAQ
Market Cap:
$1.54 billion
Price
9.99 USD
Change
-0.20%
52 weeks high
13.39
52 weeks low
0.71

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.